Bevacizumab Concept

Vocabulary Service

MeSH

Overview

subject area of

A Distinct Advantage to Intraarterial Delivery of ⁸⁹Zr-Bevacizumab in PET Imaging of Mice With and Without Osmotic Opening of the Blood–Brain Barrier Journal Articles
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial Journal Articles
A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer Journal Articles
Adjuvant Chemotherapy With or Without Biologics Including Antiangiogenics and Monoclonal Antibodies Targeting EGFR and EpCAM in Colorectal Cancer: A Systematic Review and Meta-analysis Journal Articles
Adverse Gastrointestinal Events with Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Nested Case–Control Study Journal Articles
Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study Journal Articles
Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis Journal Articles
Anti‐vascular endothelial growth factor therapy and retinal non‐perfusion in diabetic retinopathy: A meta‐analysis of randomised trials Journal Articles
Aqueous Humor Cytokines and Long-Term Response to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema Journal Articles
Bevacizumab in advanced lung cancer: in search of the right drug for the right patient. Journal Articles
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial Journal Articles
Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration Journal Articles
Changes in plasma hormones and heart rate variability in patients receiving the cardiotoxic anti-cancer agent bevacizumab Journal Articles
Displacement Affinity Release of Antibodies from Injectable Hydrogels Journal Articles
Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer Journal Articles
Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme Journal Articles
Efficacy and safety of anti-vascular endothelial growth agents for the treatment of polypoidal choroidal vasculopathy: A systematic review and meta-analysis Journal Articles
Five-Year Clinical Outcomes of Intravitreal Bevacizumab Versus Laser Photocoagulation for ROP Journal Articles
Increased incidence of retinopathy of prematurity and evolving treatment modalities at a Canadian tertiary centre Journal Articles
MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial Journal Articles
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials Conferences
Metastatic renal cell cancer treatments: An indirect comparison meta-analysis Journal Articles
Overstated Conclusions of a Pooled Analysis of Bevacizumab in Colon Cancer Journal Articles
Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial Journal Articles
Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia Conferences
Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab Journal Articles
Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: A phase II trial Journal Articles
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma Journal Articles
Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada Journal Articles
Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials Journal Articles
Same-Day Bilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections: Experience of a Large Canadian Retina Center Journal Articles
Seasonal and Environmental Variations in Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor Injection: A Six-year Review Journal Articles
Selective binding of C-6 OH sulfated hyaluronic acid to the angiogenic isoform of VEGF165 Journal Articles
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial Journal Articles
Stroke Rates after Introduction of Vascular Endothelial Growth Factor Inhibitors for Macular Degeneration: A Time Series Analysis Journal Articles
Subthreshold Compared with Threshold Macular Photocoagulation for Diabetic Macular Edema Journal Articles
Targeted therapy for metastatic renal cell carcinoma Journal Articles
The 12- and 24-Month Effects of Intravitreal Ranibizumab, Aflibercept, and Bevacizumab on Intraocular Pressure Journal Articles
The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review Journal Articles
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline Journal Articles
Treat‐and‐extend regimens of anti‐vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta‐analysis Journal Articles
Using bevacizumab to treat metastatic cancer: UK consensus guidelines Journal Articles
[Economic evaluation of bevacizumab versus ranibizumab in neovascular age-related macular degeneration]. Journal Articles